On August 27, Weiguang Biological Products (002880.SZ) announced its semi-annual report for 2024, with a half-year revenue of 0.523 billion yuan, a year-on-year increase of 14.38%; net income attributable to shareholders of the listed company was 0.1099 billion yuan, a year-on-year increase of 8.75%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.108 billion yuan, a year-on-year increase of 8.34%; and the basic earnings per share was 0.4844 yuan.
卫光生物(002880.SZ)：上半年净利润1.099亿元 同比增长8.75%
Shen Zhen Weiguang Biological Products (002880.SZ): Net income in the first half of the year was 0.1099 billion yuan, a year-on-year increase of 8.75%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.